The small-cap pharmaceutical company announced the pricing of a public stock offering.
News & Analysis: ZIOPHARM Oncology
ZIOP earnings call for the period ending September 30, 2019.
ZIOP earnings call for the period ending June 30, 2019.
ZIOP earnings call for the period ending December 31, 2018.
Can these fast-rising biotech stocks keep the momentum going?
The company's second-quarter update is fueling optimism.
A game of musical chairs on its board of directors causes investors to sing a new tune about this beaten-down biotech.
Ziopharm has been stung by a series of clinical setbacks this year, and the company is now facing a serious cash crunch to boot.
Which beaten-down biotech stock wins in a head-to-head match-up?
A disappointing setback in a key clinical trial has investors scurrying for the exit.